1. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health. 1993;83:711-716.

2. Bloch S, Rosenthal AR, Friedman L, Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol. 1977;61:531-534.

3. Granstrom PA. Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects. Br J Ophthalmol. 1982;66:464-470.

4. Granstrom PA, Norell SE. Visual ability and drug regimen: relation to compliance with glaucoma therapy. Acta Ophthalmol. 1983;61:206-219.

5. Spaeth GL. Visual loss in a glaucoma clinic, I: sociological considerations. Invest Ophthalmol. 1970;9:73-82.

6. Vincent P. Factors influencing patient non-compliance: a theoretical approach. Nurs Res. 1971;20:509-516.

7. Norell SE, Granstrom PA. Self-medication with pilocarpine among outpatients in a glaucoma clinic. Br J Ophthalmol. 1980;64:137-141.

8. Brown MM, Brown GC, Spaeth GL. Improper topical self-administration of ocular medication among patients with glaucoma. Can J Ophthalmol. 1984;19:2-5.

9. Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of noncompliance by patients prescribed eyedrops. Br J Ophthalmol. 1990;74:477-480.

10. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515-523.

11. Solomon DK, Baumgartner RP, Glascock LM, et al. Use of medication profiles to detect potential therapeutic problems in ambulatory patients. Am J Hosp Pharm. 1974;31: 348-354.

12. Geletko SM, Rana KZ. Improving adherence with complicated medication regimens. Med Health R I. 1998;81:54-57.

13. Alward PD, Wilensky JT. Determination of acetazolamide compliance in patients with glaucoma. Arch Ophthalmol. 1981;99:1973-1976.

14. MacKean JM, Elkington AR. Compliance with treatment of patients with chronic open-angle glaucoma. Br J Ophthalmol. 1983;67:46-49.

15. Norell SE, Granstrom PA, Wassen R. A medication monitor and fluorescein technique designed to study medication behaviour. Acta Ophthalmol. 1980;58:459-467.

16. Nordstrom BL, Friedman DS, Mozafari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140:598-606

17. Spooner JJ, Bullano MF, Ikeda LI, et al. Rates of discontinuation and change of glaucoma therapy in a managed care setting. Am J Manag Care. 2002;8(suppl):S262-S270.

18. Dasgupta S, Oates V, Bookhart BK, et al. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Am J Manag Care. 2002;8(suppl):S255-S261.

19. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12:393-398.

20. Marston MV. Compliance with medical regimens: a review of the literature. Nurs Res. 1970;19:312-323.

21. Mitchell JH. Compliance with medical regimens: an annotated bibliography. Health Educ Monogr. 1974;2:75-87.

22. Bigger JF. A comparison of patient compliance in treated vs untreated ocular hypertension. Trans Am Acad Ophthalmol Otolaryngol. 1976;81:277-285.

23. Kass MA, Hodapp E, Gordon M, et al. Part 1. Patient administration of eyedrops: interview. Ann Ophthalmol. 1982;14:775-779.

24. Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26:233-236.

25. Corlett AJ. Caring for older people: aids to compliance with medication. BMJ. 1996;313:926-929.

26. Walker R. Aids for eye drop administration. Pharm J. 1992;249:608.

27. Morrison J. Eye drop aids and counseling sessions for glaucoma patients. Hosp Pharm Prac. 1993;3:413-418.

28. French KS, Larrabee JH. Relationship among education material readability, client literacy, perceived beneficence, and perceived quality. J Nurs Care Qual. 1999;13:68-82.

29. Weiss BD, Reed RL, Kligman EW. Literacy skills and communication methods of low-income older persons. Pat Educ Counsel. 1995;25:109-119.

Baker DW, Parker RM, Williams MV, et al. The health care experience of patients with low literacy. Arch Fam Med. 1996;5:329-334.

Davis TC, Jackson TH, George RB, et al. Reading ability in patients in substance misuse treatment centers. Intl J Addict. 1993;28:571-582.

Meade CD, Howser DM. Consent forms: how to determine and improve their readability. Oncol Nurs Forum. 1992;19:1523-1528.

Stephens NS. Patient education materials: are they readable? Oncol Nurs Forum. 1992;19:83-85.

Merritt SL, Gates MA, Skiba K. Readability levels of selected hypercholesteremia patient education literature. Heart Lung. 1993;22:415-420.

Becker MH. The health belief model and sick role behavior. Health Educ Monogr. 1974;2:409-419.

Dunbar JM, Stunkard AJ. Adherence to diet and drug regimen. In: Rifkind B, Levy R, Dennis B, Ernst N, eds. Nutrition, Lipids, and Coronary Heart Disease. New York: Raven Press; 1979:391-423.

Dowell J, Hudson H. A qualitative study of medication-taking behaviour in primary care. Fam Pract. 1997;14:369-375.

Haynes RB. Determinants of compliance: the disease and mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:49-62.

Gurwitz JH, Yeomans SM, Glynn RJ, et al. Patient demographics in the managed care setting: the case of medical therapy for glaucoma. Med Care. 1998;36:357-369. Akafo SK, Thompson JR, Rosenthal AR. A cross-over trial comparing once daily levobunolol with once and twice daily timolol. Eur J Ophthalmol. 1995;5:172-176.

Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6:592-599.

Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10:697-704.

Kass MA, Gordon M, Mosley RE Jr, et al. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103:188-193.

Stewart WC, Sine C, Cate E, et al. Daily cost of b-adrenergic blocker therapy. Arch Ophthalmol. 1997;115:853-856.

Jampel HD, Schwartz GF, Robin AL, et al. Patient preference for eye drop characteristics. A willingness-to-pay analysis. Arch Ophthalmol. 2003;121:540-546. Stunkard AJ. Adherence to medical treatment: overview and lessons from behavioral weight control. J Psychosom Res. 1981;25:187-197.

Finnerty FA Jr. The problem of noncompliance in hypertension. Bull NY Acad Med. 1982;58:195-202.

Kosoko O, Quigley HA, Vitale S, et al. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105:2105-2111. Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol. 2005;16:114-121.

Ayanian JZ, Kohler BA, Abe T, et al. The relationship between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326-331.

52. Cohen JW. Medicaid policy and the substitution of hospital outpatient care for physician care. Health Serv Res. 1989;24:33-66.

53. The Medicaid Access Study Group. Access of Medicaid recipients to outpatient care. N Engl J Med. 1994;330:1426-1430.

54. Long SH, Settle R, Stuart B. Reimbursement and access to physicians' services under Medicaid. J Health Econ. 1986;5:235-251.

55. Kass MA, Gordon M, Meitzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol. 1986;101:524-530.

56. Norell SE. Improving medication compliance: a randomised clinical trial. BMJ. 1979; 2:1031-1033.

57. Yee RD, Hahn PM, Christensen RE. Medication monitor for ophthalmology. Am J Ophthalmol. 1974;78:774-778.

58. Blowey DL, Hebert D, Arbus GS, et al. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol. 1997;11:547-551.

59. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press; 1991:3-10.

60. Norell SE. Monitoring compliance with pilocarpine therapy. Am J Ophthalmol. 1981; 92:727-731.

61. Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997;17:126-132.

62. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.

63. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J. 1995;130:572-579.

64. Sackett DL. A compliance practicum for the busy practitioner. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:286-294.

65. Bartlett EE, Grayson M, Barker R, et al. The effects of physician communications skills on patient satisfaction, recall, and adherence. J Chronic Dis. 1984;37:755-764.

66. Cramer JA. Feedback on medication dosing enhances patient compliance. Chest. 1993;104:333-334.

67. Waitzkin H. Doctor-patient communication: clinical implications of social scientific research. JAMA. 1984;252:2441-2446.

68. Higbee M, Dukes G, Bosso J. Patient recall of physician's prescription instructions. Hosp Formulary. 1982;17(4):553-556.

69. Morisky DE, Malotte CK, Choi P, et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q. 1990;17:253-267.

70. Kooner KS, Zimmerman TJ. A glaucoma medication time-table card. Ann Ophthalmol. 1987;19:43-44.

71. Faucher D, Gunn M, Morris M, et al. Why some eye surgery patients are seeing dots. Nursing. 1993;23:41.

72. Ritch R, Liebmann J, Steinberger D. A labelling method for eyedrops to improve compliance. Ophthalmic Surg. 1993;24:861.

73. Simkins CV, Wenzloff NJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm. 1986;20: 799-802.

74. Robbins J. The Forgetful Patient: The High Cost of Improper Patient Compliance. Schering Report IX. Kenilworth, NJ: Schering Laboratories; 1987.

75. Sclar DA, Skaer TL, Chin A, et al. Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma. Clin Ther. 1991;13:396-400.

76. Chang JS Jr, Lee DA, Peturrsson G, et al. The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J Ocul Pharmacol. 1991;7:117-124.

77. Friedman DS, Cramer J, Quigley H. A more proactive approach is needed in glaucoma care. Arch Ophthalmol. 2005;123:1134-1135.

This page intentionally left blank

Reducing Blood Pressure Naturally

Reducing Blood Pressure Naturally

Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.

Get My Free Ebook

Post a comment